desipramine has been researched along with Fistula in 1 studies
Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.
Fistula: Abnormal communication most commonly seen between two internal organs, or between an internal organ and the surface of the body.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pendleton, RG | 1 |
| Bartakovits, P | 1 |
| Miller, DA | 1 |
| Mann, WA | 1 |
| Ridley, PT | 1 |
1 other study available for desipramine and Fistula
| Article | Year |
|---|---|
Studies indicating a central antisecretory site of action for desmethylimipramine (DMI).
Topics: Animals; Carbachol; Chlorpromazine; Desipramine; Dogs; Electric Stimulation; Female; Fistula; Gastri | 1970 |